BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kortunay S, Erken HA, Erken G, Genç O, Şahiner M, Turgut S, Turgut G. Orexins increase penicillin-induced epileptic activity. Peptides 2012;34:419-22. [DOI: 10.1016/j.peptides.2012.02.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Kaciński M, Budziszewska B, Lasoń W, Zając A, Skowronek-bała B, Leśkiewicz M, Kubik A, Basta-kaim A. Level of S100B protein, neuron specific enolase, orexin A, adiponectin and insulin-like growth factor in serum of pediatric patients suffering from sleep disorders with or without epilepsy. Pharmacological Reports 2012;64:1427-33. [DOI: 10.1016/s1734-1140(12)70940-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
2 Portelli J, Coppens J, Demuyser T, Smolders I. Des-acyl ghrelin attenuates pilocarpine-induced limbic seizures via the ghrelin receptor and not the orexin pathway. Neuropeptides 2015;51:1-7. [PMID: 26002375 DOI: 10.1016/j.npep.2015.04.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
3 Zhao X, Zhang Rx, Tang S, Ren Yy, Yang Wx, Liu Xm, Tang Jy. Orexin-A-induced ERK1/2 activation reverses impaired spatial learning and memory in pentylenetetrazol-kindled rats via OX1R-mediated hippocampal neurogenesis. Peptides 2014;54:140-7. [PMID: 24321199 DOI: 10.1016/j.peptides.2013.11.019] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
4 Liu L, Wang Q, Liu A, Lan X, Huang Y, Zhao Z, Jie H, Chen J, Zhao Y. Physiological Implications of Orexins/Hypocretins on Energy Metabolism and Adipose Tissue Development. ACS Omega 2020;5:547-55. [PMID: 31956801 DOI: 10.1021/acsomega.9b03106] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
5 Berhe DF, Gebre AK, Assefa BT. Orexins role in neurodegenerative diseases: From pathogenesis to treatment. Pharmacol Biochem Behav 2020;194:172929. [PMID: 32315694 DOI: 10.1016/j.pbb.2020.172929] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Çikriklar HI, Kotan D, Yücel M, Ceylan M, Çiftçi GG, Bayraktutan ÖF, Çiftçi IH. The role of Orexin-A levels in epileptic seizure. Neurosci Lett 2020;734:135097. [PMID: 32485288 DOI: 10.1016/j.neulet.2020.135097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hayatdavoudi P, Sadeghnia HR, Mohamadian-Roshan N, Hadjzadeh MA. Beneficial Effects of Selective Orexin-A Receptor Antagonist in 4-aminopyridine-induced Seizures in Male Rats. Adv Biomed Res 2017;6:162. [PMID: 29387673 DOI: 10.4103/abr.abr_262_16] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Asadi S, Roohbakhsh A, Shamsizadeh A, Fereidoni M, Kordijaz E, Moghimi A. The effect of intracerebroventricular administration of orexin receptor type 2 antagonist on pentylenetetrazol-induced kindled seizures and anxiety in rats. BMC Neurosci 2018;19:49. [PMID: 30103703 DOI: 10.1186/s12868-018-0445-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
9 Yi PL, Chen YJ, Lin CT, Chang FC. Occurrence of epilepsy at different zeitgeber times alters sleep homeostasis differently in rats. Sleep 2012;35:1651-65. [PMID: 23204608 DOI: 10.5665/sleep.2238] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
10 Kim SW, Cho KJ, Lee BI. Compensatory actions of orexinergic neurons in the lateral hypothalamus during metabolic or cortical challenges may enable the coupling of metabolic dysfunction and cortical dysfunction. Medical Hypotheses 2013;80:520-6. [DOI: 10.1016/j.mehy.2013.02.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Kordi Jaz E, Moghimi A, Fereidoni M, Asadi S, Shamsizadeh A, Roohbakhsh A. SB-334867, an orexin receptor 1 antagonist, decreased seizure and anxiety in pentylenetetrazol-kindled rats. Fundam Clin Pharmacol 2017;31:201-7. [DOI: 10.1111/fcp.12249] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
12 Erken HA, Erken G, Genç O, Kortunay S, Şahiner M, Turgut G, Turgut S. Orexins cause epileptic activity. Peptides 2012;37:161-4. [DOI: 10.1016/j.peptides.2012.06.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
13 Mokhtarpour M, Elahdadi Salmani M, Lashkarbolouki T, Abrari K, Goudarzi I. Lateral hypothalamus orexinergic system modulates the stress effect on pentylenetetrazol induced seizures through corticotropin releasing hormone receptor type 1. Neuropharmacology 2016;110:15-24. [PMID: 27395784 DOI: 10.1016/j.neuropharm.2016.07.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
14 Ng MC. Orexin and Epilepsy: Potential Role of REM Sleep. Sleep 2017;40. [DOI: 10.1093/sleep/zsw061] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
15 Ni LY, Zhu MJ, Song Y, Liu XM, Tang JY. Pentylenetetrazol-induced seizures are exacerbated by sleep deprivation through orexin receptor-mediated hippocampal cell proliferation. Neurol Sci 2014;35:245-52. [DOI: 10.1007/s10072-013-1495-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
16 Razavi BM, Farivar O, Etemad L, Hosseinzadeh H. Suvorexant, a Dual Orexin Receptor Antagonist, Protected Seizure through Interaction with GABAA and Glutamate Receptors. Iran J Pharm Res 2020;19:383-90. [PMID: 33224245 DOI: 10.22037/ijpr.2019.14688.12584] [Reference Citation Analysis]
17 Socała K, Szuster-ciesielska A, Wlaź P. SB 334867, a selective orexin receptor type 1 antagonist, elevates seizure threshold in mice. Life Sciences 2016;150:81-8. [DOI: 10.1016/j.lfs.2016.02.075] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
18 Erken HA, Koç ER, Erken G, Genç O, Çelik HT, Gökçe EC, Ayada C, Turgut S, Turgut G. Proconvulsant Effect of NUCB2/Nesfatin-1. Int J Pept Res Ther 2015;21:29-38. [DOI: 10.1007/s10989-014-9428-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]